AMPK activation and fat oxidation
Metabolaid® activates AMP-activated protein kinase (AMPK) — the master metabolic enzyme that signals the body to switch from glucose to fat as the primary fuel source. Human studies show Metabolaid® significantly increases fat oxidation during exercise, reduces respiratory exchange ratio (RER), and improves fat-burning capacity over time.
Body weight and fat mass reduction
A 12-week RCT in overweight adults showed Metabolaid® (500 mg/day) combined with exercise produced significantly greater reductions in body weight (-2.7 kg vs -0.7 kg placebo), body fat percentage, and BMI compared to exercise alone — with no dietary restriction required.
Exercise performance and endurance
Athletes taking Metabolaid® show significant improvements in time-to-exhaustion, reduced perceived exertion, and improved recovery between exercise bouts. The enhanced fat oxidation preserves glycogen stores, extending endurance performance — particularly in prolonged exercise lasting 90+ minutes.
Blood pressure and cardiovascular health
Hibiscus anthocyanins have strong clinical evidence for blood pressure reduction (meta-analyses confirm 7–13 mmHg systolic reduction), while lemon verbena verbascoside reduces arterial stiffness and inflammatory markers. The combination produces synergistic cardiovascular benefits.
Appetite regulation and satiety
Metabolaid® supplementation reduces self-reported appetite scores and improves satiety hormone profiles (GLP-1, PYY) in clinical studies. The AMPK activation mechanism includes central appetite regulation in the hypothalamus, contributing to reduced caloric intake alongside improved metabolic efficiency.
Dual AMPK activation via complementary pathways
Hibiscus anthocyanins activate AMPK via the LKB1 pathway (same as metformin), while lemon verbena verbascoside activates AMPK through the CaMKKβ calcium-dependent pathway. The combination activates AMPK more strongly than either ingredient alone — with human biopsy data confirming 3.5x greater AMPK phosphorylation with Metabolaid® vs. placebo.
Mitochondrial biogenesis via PGC-1α
AMPK activation phosphorylates and activates PGC-1α — the master regulator of mitochondrial biogenesis. Increased mitochondrial density enhances fat oxidation capacity, aerobic energy production efficiency, and exercise endurance by expanding the cell's fat-burning machinery.
ACE inhibition and blood pressure reduction
Hibiscus anthocyanins inhibit angiotensin-converting enzyme (ACE), reducing angiotensin II-mediated vasoconstriction. Combined with lemon verbena's anti-inflammatory effects on vascular endothelium, Metabolaid® provides dual-mechanism cardiovascular protection.
Randomized, double-blind, placebo-controlled trial of Metabolaid® (500 mg/day) vs. placebo combined with 3 exercise sessions/week in 54 overweight adults for 12 weeks.
54 overweight adults (BMI 25–29.9). 12-week exercise + supplementation protocol.
Metabolaid® group lost significantly more body weight (-2.7 kg vs -0.7 kg), reduced fat mass, and improved body composition vs. exercise-only placebo. Fat oxidation rates during exercise significantly increased. Published in Food & Function.
Mechanistic study examining AMPK phosphorylation in skeletal muscle biopsy samples before and after Metabolaid® supplementation in exercising adults.
Healthy adults performing standardized exercise. Muscle biopsy pre/post design.
Metabolaid® produced 3.5x greater AMPK phosphorylation in skeletal muscle vs. placebo, directly confirming the proposed mechanism of action. First human biopsy confirmation of botanical AMPK activation.